<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-29T09:27:14Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/8827" metadataPrefix="oai_dc">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/8827</identifier><datestamp>2024-03-16T01:05:27Z</datestamp><setSpec>com_10259_4219</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_4220</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson’s Disease</dc:title>
<dc:creator>Santos García, Diego</dc:creator>
<dc:creator>Laguna, Ariadna</dc:creator>
<dc:creator>Hernández Vara, Jorge</dc:creator>
<dc:creator>Deus-Fonticoba, Teresa de</dc:creator>
<dc:creator>Cores Bartolomé, Carlos</dc:creator>
<dc:creator>Feal Painceiras, María</dc:creator>
<dc:creator>Íñiguez Alvarado, María Cristina</dc:creator>
<dc:creator>García Díaz, Iago</dc:creator>
<dc:creator>Jesús, Silvia</dc:creator>
<dc:creator>Buongiorno, María Teresa</dc:creator>
<dc:creator>Planellás, Lluis L.</dc:creator>
<dc:creator>Cosgaya, Marina</dc:creator>
<dc:creator>García Caldentey, Juan</dc:creator>
<dc:creator>Caballol, Núria</dc:creator>
<dc:creator>Legarda, Inés</dc:creator>
<dc:creator>Cabo López, Iria</dc:creator>
<dc:creator>López Manzanares, Lydia</dc:creator>
<dc:creator>González Aramburu, Isabel</dc:creator>
<dc:creator>Ávila Rivera, María A.</dc:creator>
<dc:creator>Gómez Mayordomo, Víctor</dc:creator>
<dc:creator>Nogueira, Víctor</dc:creator>
<dc:creator>Puente, Víctor</dc:creator>
<dc:creator>Dotor, Julio</dc:creator>
<dc:creator>Borrue, Carmen</dc:creator>
<dc:creator>Solano Vila, Berta</dc:creator>
<dc:creator>Álvarez Saúco, María</dc:creator>
<dc:creator>Vela Desojo, Lydia</dc:creator>
<dc:creator>Escalante Arroyo, Sonia</dc:creator>
<dc:creator>Cubo Delgado, Esther</dc:creator>
<dc:creator>Carrillo Padilla, Francisco</dc:creator>
<dc:creator>Martínez Castrillo, Juan Carlos</dc:creator>
<dc:creator>Sánchez Alonso, Pilar</dc:creator>
<dc:creator>Alonso Losada, María Gema</dc:creator>
<dc:creator>López Ariztegui, Nuria</dc:creator>
<dc:creator>Gastón, Itziar</dc:creator>
<dc:creator>Kulisevsky Bojarsky, Jaume</dc:creator>
<dc:creator>Menéndez González, Manuel</dc:creator>
<dc:creator>Seijo, Manuel</dc:creator>
<dc:creator>Ruíz Martínez, Javier</dc:creator>
<dc:creator>Valero, Caridad</dc:creator>
<dc:creator>Kurtis, Mónica M.</dc:creator>
<dc:creator>González Ardura, Jessica</dc:creator>
<dc:creator>Alonso Redondo, Rubén</dc:creator>
<dc:creator>Ordás Bandera, Carlos Manuel</dc:creator>
<dc:creator>López Díaz, Luis M.</dc:creator>
<dc:creator>McAfee, Darrian</dc:creator>
<dc:creator>Martínez Martín, Pablo</dc:creator>
<dc:creator>Mir, Pablo</dc:creator>
<dc:creator>COPPADIS Study Group</dc:creator>
<dc:subject>Motor</dc:subject>
<dc:subject>Non-motor symptoms</dc:subject>
<dc:subject>Gender</dc:subject>
<dc:subject>Parkinson’s disease</dc:subject>
<dc:subject>Quality of life</dc:subject>
<dc:subject>Sex</dc:subject>
<dc:subject>Sistema nervioso-Enfermedades</dc:subject>
<dc:subject>Medicina</dc:subject>
<dc:subject>Neurología</dc:subject>
<dc:subject>Nervous system-Diseases</dc:subject>
<dc:subject>Medicine</dc:subject>
<dc:subject>Neurology</dc:subject>
<dc:description>Background and objective: Sex plays a role in Parkinson’s disease (PD) mechanisms. We analyzed sex difference manifestations among Spanish patients with PD. Patients and Methods: PD patients who were recruited from the Spanish cohort COPPADIS from January 2016 to November 2017 were included. A cross-sectional and a two-year follow-up analysis were conducted. Univariate analyses and general linear model repeated measure were used. Results: At baseline, data from 681 PD patients (mean age 62.54 ± 8.93) fit the criteria for analysis. Of them, 410 (60.2%) were males and 271 (39.8%) females. There were no differences between the groups in mean age (62.36 ± 8.73 vs. 62.8 ± 9.24; p = 0.297) or in the time from symptoms onset (5.66 ± 4.65 vs. 5.21 ± 4.11; p = 0.259). Symptoms such as depression (p &lt; 0.0001), fatigue (p &lt; 0.0001), and pain (p &lt; 0.00001) were more frequent and/or severe in females, whereas other symptoms such as hypomimia (p &lt; 0.0001), speech problems (p &lt; 0.0001), rigidity (p &lt; 0.0001), and hypersexuality (p &lt; 0.0001) were more noted in males. Women received a lower levodopa equivalent daily dose (p = 0.002). Perception of quality of life was generally worse in females (PDQ-39, p = 0.002; EUROHIS-QOL8, p = 0.009). After the two-year follow-up, the NMS burden (Non-Motor Symptoms Scale total score) increased more significantly in males (p = 0.012) but the functional capacity (Schwab and England Activities of Daily Living Scale) was more impaired in females (p = 0.001). Conclusion: The present study demonstrates that there are important sex differences in PD. Long-term prospective comparative studies are needed.</dc:description>
<dc:description>COPPADIS and the present study were developed with the help of Fundación Española de Ayuda a la Investigación en Enfermedades Neurodegenerativas y/o de Origen Genético ( https://fundaciondegen.org/) and Alpha Bioresearch (www.alphabioresearch.com). Also, we received grants from the Spanish Ministry of Economy and Competitiveness [PI16/01575] co-founded by ISCIII (Concesión de subvenciones de Proyectos de Investigación en Salud de la convocatoria 2020 de la Acción Estratégica en Salud 2017–2020 por el proyecto “PROGRESIÓN NO MOTORA E IMPACTO EN LA CALIDAD DE VIDA EN LA ENFERMEDAD DE PARKINSON”) to develop a part of the COPPADIS project.</dc:description>
<dc:date>2024-03-15T07:49:26Z</dc:date>
<dc:date>2024-03-15T07:49:26Z</dc:date>
<dc:date>2023-02</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:identifier>http://hdl.handle.net/10259/8827</dc:identifier>
<dc:identifier>10.3390/jcm12041329</dc:identifier>
<dc:identifier>2077-0383</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Journal of Clinical Medicine. 2023, V. 12, n. 4, 1329</dc:relation>
<dc:relation>https://doi.org/10.3390/jcm12041329</dc:relation>
<dc:rights>Atribución 4.0 Internacional</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>application/pdf</dc:format>
<dc:publisher>MDPI</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>